2 completed, 1 unknown. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
Follow ASLAN003: new trials by email Literature Review of ASLAN003 trials Research Report on ASLAN003
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Investigate the Efficacy and Safety of Farudodstat Compared With Its Placebo in Adult Alopecia Areata Participants Farudodstat, Placebo - Alopecia Areata | Phase 2 | Unknown | ASLAN Pharmaceuticals | 60 | 2023-04-14 | 2023-12-18 |
| A Dose Optimisation Study of ASLAN003 in Acute Myeloid Leukemia ASLAN003 - Acute Myeloid Leukemia | Phase 2 | Completed | ASLAN Pharmaceuticals | 24 | 2018-01-05 | 2021-07-06 |
| A Phase 1, 2-Part Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Doses of ASLAN003 in Healthy Elderly Subjects ASLAN003, Matched Placebo - Healthy Elderly Subjects (Age ≥55 Years) | Phase 1 | Completed | ASLAN Pharmaceuticals | 7 | 2014-10-01 | 2016-11-02 |
Alopecia Areata (1) · Leukemia, Myeloid, Acute (1)
Singapore (2) · United States (2) · Australia (1)